Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	European journal of clinical pharmacology
投稿日	2012/10/12
投稿者	Stobaugh, Derrick J; Deepak, Parakkal; Ehrenpreis, Eli D
組織名
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/23052415/

タグ:

お問合わせ

キーワード